Fennec Pharmaceuticals Inc.
Support and Resistance Levels
Past performance
News About FENC
All events for FENC
All deals for FENC
Financial Ratios
Financial Statements
FENC vs Sector & Peers
About Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina. Website fennecpharma.com
Headquarters Research Triangle Park, NC, US